The demographic and clinical characteristics of training group. Table S1. The demographic and clinical characteristics of bladder cancer (BC) patients of training group. The originally reported cytology classification included negative (â), suspicious (+â) and positive (+). Table S2. The demographic and clinical characteristics of non-malignant urinary disease (UD) patients of training group. Table S3. The demographic characteristics of healthy controls of training group (XLSX 27 kb)
Table S1. Characteristics of the study population in the training set and the validation set. (DOCX ...
Figure S4. a) Contingency table showing the frequency distribution of CCDC6 intensity IHC staining v...
Table S2. Trends in transitional cell carcinoma of the bladder Incidence-based mortality Rates by st...
Figure S5. Flow diagram of participants in the cross-sectional study according a) to the three-gene ...
Figure S4. Sensitivity, negative and positive predictive values of urine cytology, the three-gene me...
Figure S1. Flowchart of the entire study. A total of seven hypermethylated genes, differentially exp...
Figure S1. Heat map of frequent genetic aberrations in bladder cancer patient samples from cBioPorta...
Additional file 1. The file contains additional analysis. Table S1. Definitions of lifestyle factors...
Figure S1. Concentrations of UE-derived MALAT1, PCAT-1 and SPRY4-IT1 and their diagnostic performanc...
Figure S2. Validation of UE-derived MALAT1, PCAT-1 and SPRY4-IT1 as biomarkers for BC diagnosis and ...
Additional file 1: Supplementary Figure 1. The morphology distribution of BLCA patients (n=66) & Com...
Baseline characteristics and clinicopathological variables. Table with characteristics of HNSCC and ...
Figure S1. Diagnostic and prognostic ability of ProCUrE and age-adjusted PSA in the training cohort....
Table S1. Clinicopathological characteristics of 167 patient samples. Table S2. Correlation between ...
Clinicopathologic characteristics of bladder cancer patient samples in microarray datasets. Figure S...
Table S1. Characteristics of the study population in the training set and the validation set. (DOCX ...
Figure S4. a) Contingency table showing the frequency distribution of CCDC6 intensity IHC staining v...
Table S2. Trends in transitional cell carcinoma of the bladder Incidence-based mortality Rates by st...
Figure S5. Flow diagram of participants in the cross-sectional study according a) to the three-gene ...
Figure S4. Sensitivity, negative and positive predictive values of urine cytology, the three-gene me...
Figure S1. Flowchart of the entire study. A total of seven hypermethylated genes, differentially exp...
Figure S1. Heat map of frequent genetic aberrations in bladder cancer patient samples from cBioPorta...
Additional file 1. The file contains additional analysis. Table S1. Definitions of lifestyle factors...
Figure S1. Concentrations of UE-derived MALAT1, PCAT-1 and SPRY4-IT1 and their diagnostic performanc...
Figure S2. Validation of UE-derived MALAT1, PCAT-1 and SPRY4-IT1 as biomarkers for BC diagnosis and ...
Additional file 1: Supplementary Figure 1. The morphology distribution of BLCA patients (n=66) & Com...
Baseline characteristics and clinicopathological variables. Table with characteristics of HNSCC and ...
Figure S1. Diagnostic and prognostic ability of ProCUrE and age-adjusted PSA in the training cohort....
Table S1. Clinicopathological characteristics of 167 patient samples. Table S2. Correlation between ...
Clinicopathologic characteristics of bladder cancer patient samples in microarray datasets. Figure S...
Table S1. Characteristics of the study population in the training set and the validation set. (DOCX ...
Figure S4. a) Contingency table showing the frequency distribution of CCDC6 intensity IHC staining v...
Table S2. Trends in transitional cell carcinoma of the bladder Incidence-based mortality Rates by st...